logologo
QuantliQuantli

AVITA Medical Inc

RCEL

NASDAQ

Biotechnology

$7.85

USD

-0.16 (-2.00%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $247.72M

Volume 270.6K

Price Target

$7.00$7.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $7.00 and a min estimate of $7.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$7.00

-$1.7 vs prior

Implied Upside

-10.8%

-21.3% vs prior

Analyst Covering

1

-2 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

25%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Ryan Zimmerman

BTIG

Buy

Upgraded

1 week ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

MGNX

MacroGenics Inc

$4.22

+3.4%

AKBA

Akebia Therapeutics Inc

$0.8700

+0.4%

GLSI

Greenwich Lifesciences Inc

$16.80

+2.6%

ARCT

Arcturus Therapeutics Holdings Inc

$8.23

+4.7%

CNXU

Conexeu Sciences Inc

$8.90

+11.7%

TARA

Protara Therapeutics Inc

$3.97

+0.8%

ORGO

Organogenesis Holdings Inc

$1.79

+1.7%